Effect of Treatment of Residual Disease After Immunotherapy-Based Combinations on Complete Response Rate of Patients With Metastatic Renal Cell Carcinomas.
Moinard-Butot F, Oriel M, Tricard T, Cazzato RL, Pierard L, Gaillard V, Werle P, Lindner V, Martin S, Schuster C, Roy C, Burgy M, Anthony A, Bigot C, Boudier P, Fritsch A, Olland A, Malouf G, Lang H, Barthélémy P.
Moinard-Butot F, et al. Among authors: martin s.
Clin Genitourin Cancer. 2024 Jun 5;22(5):102134. doi: 10.1016/j.clgc.2024.102134. Online ahead of print.
Clin Genitourin Cancer. 2024.
PMID: 38909529